• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Treatment outcomes with telaprevir-based therapy for HIV/hepatitis C coinfected patients are comparable with hepatitis C monoinfected patients.

作者信息

O'Neil Conar R, Pang Jack Xq, Lee Samuel S, Swain Mark G, Burak Kelly W, Klein Patricia, Myers Robert P, Kapler Jeff, Gill Michael J, Labrie Martin, Coffin Carla S

机构信息

Department of Internal Medicine, University of Calgary Cumming School of Medicine, Calgary, Alberta.

Calgary Liver Unit, Division of Gastroenterology and Hepatology, University of Calgary Cumming School of Medicine, Calgary, Alberta.

出版信息

Can J Infect Dis Med Microbiol. 2015 Nov-Dec;26(6):293-6. doi: 10.1155/2015/974871.

DOI:10.1155/2015/974871
PMID:26744584
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4692296/
Abstract
摘要

相似文献

1
Treatment outcomes with telaprevir-based therapy for HIV/hepatitis C coinfected patients are comparable with hepatitis C monoinfected patients.基于替拉瑞韦的疗法对HIV/丙型肝炎合并感染患者的治疗效果与丙型肝炎单一感染患者相当。
Can J Infect Dis Med Microbiol. 2015 Nov-Dec;26(6):293-6. doi: 10.1155/2015/974871.
2
Rates of sustained virological response 12 weeks after the scheduled end of direct-acting antiviral (DAA)-based hepatitis C virus (HCV) therapy from the National German HCV registry: does HIV coinfection impair the response to DAA combination therapy?德国国家丙型肝炎病毒（HCV）登记处登记的直接作用抗病毒（DAA）为基础的 HCV 治疗结束后 12 周持续病毒学应答率：HIV 合并感染是否会影响 DAA 联合治疗的应答？
HIV Med. 2018 Apr;19(4):299-307. doi: 10.1111/hiv.12579. Epub 2018 Jan 25.
3
Boceprevir and telaprevir-based regimens for the treatment of hepatitis C virus in HIV/HCV coinfected patients.基于博赛泼维与特拉泼维的治疗方案用于治疗HIV/HCV合并感染患者的丙型肝炎病毒
Eur J Gastroenterol Hepatol. 2015 Feb;27(2):123-9. doi: 10.1097/MEG.0000000000000241.
4
[Comparative analysis of the safety of triple therapy with telaprevir between HCV monoinfected and HIV coinfected patients].[特拉匹韦三联疗法在丙型肝炎病毒单感染和人类免疫缺陷病毒合并感染患者中的安全性比较分析]
Farm Hosp. 2014 Jan 1;38(1):25-9. doi: 10.7399/FH.2014.38.1.1143.
5
Telaprevir-based therapy in patients coinfected with chronic hepatitis C virus infection and HIV: INSIGHT study.基于替拉瑞韦的疗法用于慢性丙型肝炎病毒感染与HIV合并感染患者：INSIGHT研究
J Antimicrob Chemother. 2016 Jan;71(1):244-50. doi: 10.1093/jac/dkv323. Epub 2015 Oct 19.
6
Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.HIV与丙型肝炎病毒合并感染患者肝移植后的生存情况及丙型肝炎病毒复发：单中心经验
Transplant Proc. 2009 Apr;41(3):1041-3. doi: 10.1016/j.transproceed.2009.02.030.
7
Cognitive function, mood and health-related quality of life in hepatitis C virus (HCV)-monoinfected and HIV/HCV-coinfected individuals commencing HCV treatment.开始接受丙型肝炎病毒（HCV）治疗的HCV单一感染和HIV/HCV合并感染个体的认知功能、情绪及健康相关生活质量
HIV Med. 2007 Apr;8(3):192-202. doi: 10.1111/j.1468-1293.2007.00452.x.
8
Lower Ribavirin Plasma Concentrations in HCV/HIV-Coinfected Patients Than in HCV-Monoinfected Patients Despite Similar Dosage.尽管剂量相似，但丙型肝炎病毒/艾滋病病毒合并感染患者的利巴韦林血浆浓度低于丙型肝炎病毒单一感染患者。
Ther Drug Monit. 2015 Dec;37(6):751-5. doi: 10.1097/FTD.0000000000000226.
9
Increased risk of hip fracture associated with dually treated HIV/hepatitis B virus coinfection.双重治疗的HIV/乙型肝炎病毒合并感染与髋部骨折风险增加相关。
J Viral Hepat. 2015 Nov;22(11):936-47. doi: 10.1111/jvh.12398. Epub 2015 Mar 6.
10
In vivo evidence that the cannabinoid receptor 2-63 RR variant is associated with the acquisition and/or expansion of HIV infection.体内证据表明，大麻素受体 2-63RR 变体与 HIV 感染的获得和/或扩展有关。
HIV Med. 2018 Oct;19(9):597-604. doi: 10.1111/hiv.12638. Epub 2018 Jun 22.

引用本文的文献

1
Real-world treatment of hepatitis C with second-generation direct-acting antivirals: initial results from a multicentre Canadian retrospective cohort of diverse patients.第二代直接作用抗病毒药物在丙型肝炎真实世界治疗中的应用：来自加拿大一个多中心、针对不同患者的回顾性队列研究的初步结果。
CMAJ Open. 2018 Jan 5;6(1):E12-E18. doi: 10.9778/cmajo.20170059.

本文引用的文献

1
Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1.来迪派韦和索磷布韦用于治疗合并感染HIV-1的丙型肝炎病毒患者。
N Engl J Med. 2015 Aug 20;373(8):705-13. doi: 10.1056/NEJMoa1501315. Epub 2015 Jul 21.
2
CIHR Canadian HIV Trials Network Co-Infection and Concurrent Diseases Core: Updated Canadian guidelines for the treatment of hepatitis C infection in HIV-hepatitis C coinfected adults.加拿大健康研究院加拿大艾滋病毒试验网合并感染和并发疾病核心：加拿大艾滋病毒合并丙型肝炎感染成人丙型肝炎治疗指南更新。
Can J Infect Dis Med Microbiol. 2014 Nov-Dec;25(6):311-20. doi: 10.1155/2014/251989.
3
An update on the management of chronic hepatitis C: 2015 Consensus guidelines from the Canadian Association for the Study of the Liver.慢性丙型肝炎管理的最新进展：加拿大肝病研究协会 2015 年共识指南。
Can J Gastroenterol Hepatol. 2015 Jan-Feb;29(1):19-34. doi: 10.1155/2015/692408. Epub 2015 Jan 13.
4
Telaprevir combination therapy in HCV/HIV co-infected patients (INSIGHT study): sustained virologic response at 12 weeks final analysis.替拉普韦联合疗法用于丙型肝炎病毒/人类免疫缺陷病毒合并感染患者（INSIGHT研究）：12周最终分析时的持续病毒学应答
J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19626. doi: 10.7448/IAS.17.4.19626. eCollection 2014.
5
Management of hepatitis C virus and human immunodeficiency virus coinfection.
Minerva Gastroenterol Dietol. 2014 Sep;60(3):165-75.
6
Protease inhibitor-based triple therapy is highly effective for hepatitis C recurrence after liver transplant: a multicenter experience.基于蛋白酶抑制剂的三联疗法对肝移植后丙型肝炎复发高度有效：一项多中心经验。
Ann Hepatol. 2014 Sep-Oct;13(5):525-32.
7
Liver stiffness by transient elastography predicts liver-related complications and mortality in patients with chronic liver disease.瞬时弹性成像技术检测肝脏硬度可预测慢性肝病患者的肝脏相关并发症和死亡率。
PLoS One. 2014 Apr 22;9(4):e95776. doi: 10.1371/journal.pone.0095776. eCollection 2014.
8
Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection.来迪派韦索磷布韦片与索磷布韦联用治疗初治的 HCV 基因 1 型感染。
N Engl J Med. 2014 May 15;370(20):1889-98. doi: 10.1056/NEJMoa1402454. Epub 2014 Apr 11.
9
Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection.来迪派韦索磷布韦片治疗既往治疗的 HCV 基因 1 型感染。
N Engl J Med. 2014 Apr 17;370(16):1483-93. doi: 10.1056/NEJMoa1316366. Epub 2014 Apr 11.
10
Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis.聚乙二醇干扰素α-2a 联合利巴韦林治疗慢性丙型肝炎
N Engl J Med. 2014 May 15;370(20):1879-88. doi: 10.1056/NEJMoa1402355. Epub 2014 Apr 10.